Otto Erik - 11 Aug 2025 SCHEDULE 13G/A Report for Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO)

Filing Manager: Otto Erik
Reporting Manager: Otto Erik
Security: Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value
Symbol: GLTO
Shares outstanding: 20,864,198 shares
Disclosed Ownership: 1,690,000 shares
Ownership: 8.1%
Form type: SCHEDULE 13G/A
Filing time: 11 Aug 2025, 13:04:30 UTC
Date of event: 11 Aug 2025
Next filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Otto Erik	8.1%	1,690,000	1,690,000		Erik Otto	Individual